A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma - Schnitzbauer, A A; Zuelke, C; Graeb, C (BMC Cancer, 2010)
et al.